CRISPR Therapeutics AG

32.63
-0.03 (-0.09%)
At close: Apr 04, 2025, 3:59 PM
32.23
-1.23%
After-hours: Apr 04, 2025, 04:56 PM EDT

CRISPR Therapeutics AG Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
-366.25M -153.61M -650.17M 377.66M -348.87M 66.86M -164.98M -68.36M -23.2M -25.83M -6.8M
19.26M 19.84M 24.17M 17.95M 9.18M 4.72M 3.52M 3.02M 925K 127K 38K
86.57M 81.03M 97.95M 102.39M 66.02M 44.06M 34.98M 18.87M 10.84M 3.68M 695K
-18.73M 3.33M 14.38M 27.02M 33.48M -48.42M -1M -21.24M 1.83M 81.71M 1.53M
-38.62M -14.04M 12.47M 14.11M 1.86M -10.53M 15.41M 1.75M 8.05M 97K -260K
n/a n/a n/a n/a n/a n/a 4.28M n/a -53.71M -20K n/a
156.27M -193.59M 19.84M 26.86M 33.44M -48.43M 10.55M -25.39M 1.78M 81.37M 1.53M
-142.77M -260.38M -495.74M 538.97M -238.37M 56.68M -96.24M -70.1M -55.31M 59.43M -4.79M
-1.9M -11.97M -37.19M -81.7M -18.36M -6.68M -2.77M -7.81M -3.02M -1.15M n/a
n/a n/a 221.47M 953.73M 522.81M 8.01M n/a n/a -100K n/a n/a
-1.46B -1.07B -1.42B -1.51B -594M n/a n/a -500K -100K n/a n/a
1.21B 1.45B 1.2B 555.6M 71.19M n/a n/a n/a n/a n/a n/a
-23.18M -2.5M -221.47M -953.73M -522.81M 8.01M n/a -500K 35M n/a n/a
-280.48M 374.65M -258.65M -1.04B -541.17M 1.32M -2.77M -8.31M 31.88M -1.15M n/a
n/a n/a n/a n/a n/a n/a n/a n/a 35.01M 38.24M n/a
n/a n/a n/a n/a n/a n/a -57K n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
31.29M 29.94M 37.62M 37.68M 33.86M 15.96M 8.94M 2.61M -1.78M -127K -36K
331.98M 62.66M 38.59M 250.94M 1.02B 430.98M 315.93M 2.61M 183.22M 96.73M 5.12M
-91.29M 177.01M -715.88M -245.52M 236.66M 489M 216.9M -75.76M 159.56M 155.02M 584K
-144.68M -272.35M -532.93M 457.27M -256.72M 49.99M -99.01M -77.91M -58.33M 58.27M -4.79M